Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
Two sibling from a consanguineous Puerto Rican marriage were found to have a juvenile-onset type of lipidosis first noted at age 2 1/2 by expressing difficulties with motor function and developmental delay. They continued to deteriorate, showing muscle atrophy, spasticity, and loss of speech, and death occurred at ages 7 and 8. Examination of the brains from these patients revealed that the concentration of GM2 ganglioside was about 56% of the total gangliosides. Hexosaminidase and percent hexosaminidase A (HEX A) and other lysosomal enzymes were normal in cultured skin fibroblasts, liver, and brain. The concentration of the activator protein required for the enzymatic hydrolysis of GM2 ganglioside was in high normal levels in the brain of the patient available. However, the HEX A from the patient's brain and liver as well as from skin fibroblast lysates could not be activated to hydrolyze GM2 ganglioside by the activator protein from a control or himself. The HEX A from a control could be activated by the activator protein from controls or this patient. These patients appear to have a defect in HEX A, which does not affect it heat stability, electrophoretic migration, and activity toward fluorogenic substrates, but may affect the binding of the activator protein required for GM2 ganglioside hydrolysis. We propose to call these patients the AMB variant of GM2 gangliosidosis to denote the mutation in HEX A but with normal levels of HEX A and B with synthetic substrates. This is to distinguish these patients from those missing the activator protein and normal HEX A and B levels.
D001921:Brain / Q000378:metabolism; D002648:Child; D003241:Consanguinity; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D005678:G(M2) Ganglioside / Q000378:metabolism; D014644:Genetic Variation; D006023:Glycoproteins; D054818:Hexosaminidase A; D006596:Hexosaminidases / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008099:Liver / Q000378:metabolism; D008297:Male; D008854:Microscopy, Electron; D011506:Proteins / Q000378:metabolism*; D049231:Saposins; D012867:Skin / Q000378:metabolism; D049128:Sphingolipid Activator Proteins; D013661:Tay-Sachs Disease / Q000235:genetics* / Q000378:metabolism; D001619:beta-N-Acetylhexosaminidases
D006023:Glycoproteins; C483345:PSAP protein, human; D011506:Proteins; D049231:Saposins; D049128:Sphingolipid Activator Proteins; D005678:G(M2) Ganglioside; D006596:Hexosaminidases; D054818:Hexosaminidase A; D001619:beta-N-Acetylhexosaminidases